Cardiac Valvular Medicine
Experimental studies in the field of cardiac valve biology are now demonstrating that the cardiac valve disease process is an active biology with risk factors analogous to vascular risk factors. Understanding the risk factors is also evolving rapidly, giving physicians and scientists insight into t...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
London :
Springer London : Imprint: Springer,
2013.
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- 1.Natural History of Aortic Valve Stenosis
- 2. Cardiovascular Risk Factors for Calcific Aortic Valve Disease
- 3.Bicuspid Aortic Valve Disease: From Bench to Bedside
- 4.Experimental Evidence for the Role of Atherosclerosis in Calcific Aortic Valve Disease
- 5.The Electrocardiogram as a Risk Predictor in Asymptomatic Aortic Stenosis
- 6.Exercise Testing in Aortic Stenosis and in Mitral Regurgitation
- 7. Detection of Calcium in the Aortic Valve by Non- Invasive Imaging
- 8.Assessment of Aortic Stenosis Severity:Determining Timing to Surgery
- 9.Balloon Aortic Valvuloplasty
- 10.Imaging for TAVI
- 11.Transcutaneous Aortic Valve Implantation
- 12.Role of statins in valvular heart disease: Rheumatic valve disease and bioprosthetic valves
- 13.Slowing the Progression of Aortic Stenosis – The Emerging Role of Bisphosphonates
- 14.LDL-Density-Theory:Implications for Future Clinical Trials
- 15.Infective Endocarditis: New Recommendations and Perspectives
- 16.Assessment and Timing to Intervention of Mitral Regurgitation
- 17. Biology of Mitral Valve Disease
- 18.Mitral Valve Devices
- 19.Anatomy and Pathology of Right-sided atrioventricular and semilunal valves
- 20.Mechanisms, Evaluation and Management of Tricuspid Regurgitation.